Selected Experience
We utilize our broad and diverse experience to achieve optimal outcomes for our clients in MedTech investment banking. We have experience running public and private multinational firms at the CFO, CEO, and Board level, so we understand what makes a firm succeed from the ground up. We have accomplished divestitures and MedTech acquisitions in the US and across borders in our own firms. Members of the team have roots in the discipline of commercial banking, so we also understand the importance of financial focus. This all comes together for a special understanding of how executing on your long-term strategy will drive results.
In the 2023 world of investment banking, we have advised and executed on transactions with buyers and sellers, including billion-dollar publicly traded US corporations and privately held middle-market enterprises. This spans across MedTech and includes polymers and metals, contract manufacturing and OEM to packaging and distribution. Geographic coverage is similarly diverse, including MedTech experience in the US, Europe, Asia and Israel for clients.
COMPOSITION OF DEVICE TECHNOLOGIES: IN-DEVELOPMENT US-BASED MEDICAL DEVICES BY SUBSECTOR. SOURCE: MIKE QUIGLEY, DEVICE INNOVATION LANDSCAPE.
We believe our investment banking track record has created a positive impact, and helped to build large and small businesses that can thrive in the MedTech industry.
We understand the power of a network. Accordingly, we work with select advisors and others who can shape and form the execution of our assignments to the exact needs of our clients. This network also provides us access into all sized firms, from the plant floor to the C-Suite. This approach provides us with unrivaled access to leaders that make the MedTech industry move.
OUTSOURCING RATES OF DIFFERENT ORTHOPAEDIC COMPONENTS BY MANUFACTURING PROCESS (SOURCE: AVICIENNE ANALYSIS 2019)